戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 taneously or as part of a hereditary disease neurofibromatosis type 2.
2 first case of coexistence of gastrinoma with neurofibromatosis type 2.
3 ation of schwannoma tumours in patients with neurofibromatosis type 2.
4 aracterized by abnormal vasculature, such as neurofibromatosis type 2.
5 y benign, and are frequently associated with neurofibromatosis type 2.
6 the remainder acquire a de novo mutation for neurofibromatosis type 2.
7 ical findings, and management strategies for neurofibromatosis type 2.
8                                           In neurofibromatosis type 2, a dominantly inherited tumor d
9 nd hearing loss is a serious complication of neurofibromatosis type 2, a genetic condition associated
10 umours that occur in patients suffering from neurofibromatosis type 2, all spontaneous schwannomas an
11  refers to an Italian 69 year old woman with neurofibromatosis type 2 and a pancreatic gastrinoma.
12 om 21 vestibular schwannomas associated with neurofibromatosis type 2 and from 22 sporadic schwannoma
13                Ten consecutive patients with neurofibromatosis type 2 and progressive vestibular schw
14  hearing in some, but not all, patients with neurofibromatosis type 2 and was associated with a reduc
15 xternal ophthalmoplegia, myotonic dystrophy, neurofibromatosis type 2, and basal cell nevus syndrome.
16 is a tumor suppressor protein encoded by the neurofibromatosis type 2 gene NF2.
17 estibular schwannoma cases collated from the neurofibromatosis type 2 genetic testing service in the
18 omatosis type 1, whereas an association with neurofibromatosis type 2 has never been reported.
19 ive tumor suppressor protein associated with neurofibromatosis type 2, in the nucleus of some cells.
20                                              Neurofibromatosis type 2 is an autosomal dominant disord
21                                              Neurofibromatosis type 2 is an autosomal-dominant multip
22                                              Neurofibromatosis type 2 is an inherited autosomal disor
23                                              Neurofibromatosis type 2 is an inherited, neoplastic dis
24 ed schwannomatosis (NF2-SWN, formerly called neurofibromatosis type 2) is a tumor predisposition synd
25 erlin/NF2 (moesin-ezrin-radixin-like protein/neurofibromatosis type 2) is a tumor suppressor found to
26 related schwannomatosis, previously known as neurofibromatosis type 2, is a genetic disorder characte
27      We also show that KIBRA associates with neurofibromatosis type 2/Merlin in a Ser(539) phosphoryl
28 ents with neurofibromatosis type-1 (NF-1) or neurofibromatosis type-2 (NF-2).
29                                          The neurofibromatosis type 2 NF2 gene product, merlin, is a
30 ng in approximately 35%-40% of patients with neurofibromatosis type 2 (NF2) and progressive vestibula
31 of the tumor suppressor NF2/merlin underlies neurofibromatosis type 2 (NF2) and some sporadic tumors.
32 iology of neurofibromatosis type 1 (NF1) and neurofibromatosis type 2 (NF2) as they relate to the dev
33 g loss is one of the most common symptoms of neurofibromatosis type 2 (NF2) caused by vestibular schw
34 thern blot analysis has shown that the human neurofibromatosis type 2 (NF2) cDNA hybridizes to multip
35                  INTRODUCTION: Patients with neurofibromatosis type 2 (NF2) develop bilateral cochleo
36 teral vestibular schwannomas associated with neurofibromatosis type 2 (NF2) experience significant mo
37 n the long arm of chromosome 22 and near the neurofibromatosis type 2 (NF2) gene (22q12) were most fr
38             In this study, we have evaluated neurofibromatosis type 2 (NF2) gene alterations in eight
39                             Mutations in the neurofibromatosis type 2 (NF2) gene cause formation of s
40                                          The neurofibromatosis type 2 (NF2) gene is commonly mutated
41            Loss of function mutations in the neurofibromatosis Type 2 (NF2) gene, coding for a tumour
42                                              Neurofibromatosis type 2 (NF2) is a dominantly inherited
43                                              Neurofibromatosis type 2 (NF2) is a genetic disorder cha
44                                              Neurofibromatosis type 2 (NF2) is a multiple neoplasia s
45                                              Neurofibromatosis type 2 (NF2) is a rare disorder that c
46                                              Neurofibromatosis type 2 (NF2) is a tumor predisposition
47                                              Neurofibromatosis type 2 (NF2) is an autosomal dominant
48                                              Neurofibromatosis type 2 (NF2) is an autosomal dominant
49                                              Neurofibromatosis type 2 (NF2) is an autosomal dominant
50                                              Neurofibromatosis type 2 (NF2) is an autosomal-dominant
51                                              Neurofibromatosis type 2 (NF2) is an autosomal-dominant
52                                              Neurofibromatosis type 2 (NF2) is an inherited disorder
53                                              Neurofibromatosis type 2 (NF2) is caused by mutations in
54 e patient suggests possible association with neurofibromatosis type 2 (NF2) or schwannomatosis.
55 on sporadic tumors and hallmarks of familial neurofibromatosis type 2 (NF2) that develop predominantl
56                                          The neurofibromatosis type 2 (NF2) tumor suppressor gene enc
57                          Inactivation of the neurofibromatosis type 2 (NF2) tumor suppressor gene fun
58 ort here that liver-specific deletion of the neurofibromatosis type 2 (Nf2) tumor suppressor gene in
59                 We previously identified the neurofibromatosis type 2 (NF2) tumor suppressor Merlin a
60                                          The neurofibromatosis type 2 (NF2) tumor suppressor, Merlin,
61                                          The neurofibromatosis type 2 (NF2) tumor suppressor, Merlin,
62                   Merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene, is
63                                          The neurofibromatosis type 2 (NF2) tumor-suppressor protein
64                 Despite intense study of the neurofibromatosis type 2 (NF2) tumor-suppressor protein
65 vant targets, we examined the role of YAP in neurofibromatosis type 2 (NF2) using cell and animal mod
66 uirement for the PAKs in the pathogenesis of Neurofibromatosis type 2 (NF2), a dominantly inherited c
67                                              Neurofibromatosis type 2 (NF2), a dominantly inherited t
68 ions in the merlin tumor suppressor underlie neurofibromatosis type 2 (NF2), a familial autosomal dom
69 function mutations or deletions in NF2 cause neurofibromatosis type 2 (NF2), a multiple tumor forming
70  mutations underlie inherited tumor syndrome neurofibromatosis type 2 (NF2), as well as various spora
71 s of expression of merlin is responsible for neurofibromatosis type 2 (NF2), which is characterized b
72 ene in a panel of 239 schwannoma tumours: 97 neurofibromatosis type 2 (NF2)-related schwannomas, 104
73                                              Neurofibromatosis Type 2 (NF2)-related schwannomatosis i
74                                              Neurofibromatosis type 2 (NF2)-related schwannomatosis i
75 cally or as part of the hereditary condition neurofibromatosis Type 2 (NF2).
76 ed with increased mortality in patients with neurofibromatosis type 2 (NF2).
77 th germ line as well as somatic mutations in neurofibromatosis type 2 (NF2).
78  Merlin, the Drosophila homolog of the human Neurofibromatosis type-2 (NF2) tumor-suppressor gene, an
79   In humans, mutations in the NF2 gene cause neurofibromatosis type-2 (NF2), a cancer syndrome charac
80 lly and in the context of schwannomatosis or neurofibromatosis type 2 or 1.
81                                              Neurofibromatosis type 2 patients develop schwannomas, m
82 eral point mutants of Merlin associated with neurofibromatosis type 2 that display an aberrant phosph
83                                          The neurofibromatosis type 2 tumor suppressor gene is inacti
84                                          The neurofibromatosis type 2 tumor suppressor gene, NF2, is
85                                          The neurofibromatosis type 2 tumor suppressor protein, merli
86 hese actions of ezrin are antagonized by the neurofibromatosis type 2 tumor-suppressor protein merlin
87 examined from an additional 39 patients with neurofibromatosis type 2 who were retrospectively identi